Quality of life in patients with psoriasis: The contribution of clinical variables and psoriasis-specific stress

British Journal of Dermatology

Volumn 137, Issue 5, 1997, Pages 755-760

  Fortune, D G ^a,b   Main, C J ^b   O'Sullivan, T M ^a,b   Griffiths, C E M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; COPING BEHAVIOR; DISABILITY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MENTAL STRESS; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE;

EID: 0030689770     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb01113.x     Document Type: Article

References (20)

1. Cairns B. Measuring health outcomes (letter). Br Med J 1996; 313: 6.
2. Morgan M, McCreedy R, Simpson J, Hay RJ. Dermatology quality of life scales - a measure of the impact of skin diseases. Br J Dermatol 1997; 136: 202-6.
3. de Jong EMG, Seegers BAM, Gulinck MK et al. Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatol 1996; 193: 300-3.
4. O'Donnell BF, Lawlor F, Simpson J et al. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197-201.
5. Eun HC, Finlay AY. Measurement of atopic dermatitis disability. Ann Dermatol 1990; 123: 751-6.
6. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-16.
7. Finlay AY, Kelly S. Psoriasis - an index of disability. Clin Exp Dermatol 1987; 12: 8-11.
8. Gupta MA, Gupta AK. The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol (Stockh) 1995; 75: 240-3.
9. Hickey A, Bury G, O'Boyle C et al. A new short form individual quality of life measure (SEIQoL-DW) in a cohort of individuals with HIV/AIDS. Br Med J 1996; 313: 29-33.
10. Ginsburg I. Psychological and psychophysiological aspects of psoriasis. Dermatol Clin 1995; 13: 793-803.
11. Fredricksson T, Petterson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44.
12. Naldi L, Parrazini F, Brevi A et al. A Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol 1992; 127: 212-17.
13. Ware JE, Sherbourne CD. The MOS 36-item Short Form Health Survey (SF-36); 1: conceptual framework and item selection. Med Care 1992; 30: 473-83.
14. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CEM. Assessing illness-related stress in psoriasis: the psychometric properties of the Psoriasis Life Stress Inventory. J Psychosom Res 1997; 42: 467-475.
15. Finlay AY, Khan GK, Luscombe D, Salek MS. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatology 1990; 123: 751-6.
16. Petrie K, Weinman J, Sharpe N, Buckley J. Role of patients' view of their illness in predicting return to work and functioning after myocardial infarction: longitudinal study. Br Med J 1996; 312: 1191-4.
17. Moss-Morris R, Petrie K, Weinman J. Functioning in chronic fatigue syndrome: do illness perceptions play a regulatory role? Br J Health Psychol 1996; 1: 15-25.
18. Bennett P, Thomas B, Gawkrodger DJ. Anxiety and psoriasis. Practitioner 1993; 237: 536-9.
19. Hardy E, Cotterill J. A study of depression and obsessionality in dysmorphophobic and psoriatic patients. Br J Psychiatry 1982; 140: 19-23.
20. O'Neill P, Kelly P. Postal questionnaire study of disability in the community associated with psoriasis. Br Med J 1996; 313: 919-21.